Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy

Fig. 5

Flow cytometer analyses of the apoptotic and necrotic cells after 24 h’ incubation with different preparations. *P < 0.05, vs the ratio of AV positive cells in controlled group, #P < 0.05, vs the ratio of AV positive cells in free gefitinib group, ##P < 0.01, vs the ratio of AV positive cells in free gefitinib group. Results are expressed as mean ± SD (n = 3)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us